Research
Routine invasive procedures for stable heart disease found to offer no long-term survival advantage over drug therapy
The Brief
- An international study finds that patients with stable heart disease and abnormal stress tests do not live longer when given early invasive procedures compared with initial drug and lifestyle treatment.
- The finding concerns long-term survival specifically, as reported by Medical Xpress on 2026-11-10.
Why it matters
It challenges the assumption that routine early invasive procedures extend life for stable heart disease patients, which bears on how clinicians and health systems weigh invasive versus medical treatment strategies.
Who’s affected
- cardiologists and clinicians treating stable coronary disease
- patients with stable heart disease and abnormal stress tests
- health policy makers and payers
- #cardiology
- #stable heart disease
- #invasive procedures
- #drug therapy
- #survival
Patients with stable heart disease and abnormal stress tests who have invasive procedures early in their care do not live longer than those initially treated with drugs and lifestyle changes alone, an international study shows.
Timeline
Medical Xpress reports that the international study found no long-term survival advantage for early invasive procedures over drug therapy
Medical Xpress - latest medical and health news stories
Routine invasive procedures for stable heart disease found to offer no long-term survival advantage over drug therapy